Galpha Labs plans Rs 50 crore IPO by Sept

Mumbai-based Galpha Laboratories is planning a Rs 50 crore initial public offering by September this year. The funds will be used for the company's expansion plans in the domestic as well as global markets.

Galpha, a player in the segments of nutritional supplements, antibiotics, gastro-intestinal and pain management formulations, plans to pick up potential brands as part of its market expansion plan. Besides, it proposes to set up a facility to cater to the regulated markets overseas.

Galpha was established in 1986 in the field of pharmaceutical marketing. It started its operations in the eastern and north eastern markets in the country with a handful of products.

It strengthened its product portfolio with the introduction of a range of nutritional products under its flagship brand ""B-Colen.

The company entered into the antibiotics segment with the Odicef brand, which is now a brand leader.

According to company sources, Galpha has around 100 products in its portfolio and has a sales team of about 600.

The company is now setting up its new formulation facility at Baddi in Himachal Pradesh, which is expected to be commissioned soon.

With the recent launch of an exclusive export division, Galpha has chartered out its course to be a global player by exporting various products to the developing countries.